The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
      View

Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy SolutionsCommitment to partnership and joint innovation for cell and gene therapies

      View

Press Release / Nov 29, 2023
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDCHovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.

      View

Press Release / Mar 07, 2023
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and ExpertiseHovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents

      View

Article / Jun 02, 2021
Cleaning Continuous Manufacturing EquipmentPharmaceutical Technology, 2 Junho 2021

Browser not supported

Search

Types

Press Room

Categories

Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions

Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise

Cleaning Continuous Manufacturing Equipment